Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the IUPAC name (2S)-1-(dimethylamino)-3-{4-[ (4-{ 2-methylimidazo [1, 2-a ] pyridin -3 - yl } pyrimidin - ₂ - yl ) amino ] phenoxy } propan -₂ - ol. It belongs to the class of imidazopyridines and aminopyrimidines. The compound is listed as an experimental pharmaceutical in chemical databases such as DrugBank and PubChem but does not have an assigned therapeutic indication or known mechanism of action in humans. It has been used as a ligand in protein structure studies and appears primarily in research contexts rather than clinical development or approved drug products.[1][6][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol.